Companies: 10,795·Total market cap: $144.5T
AnGes, Inc.

AnGes, Inc.

AMGXFOTCHealthcare● Active
$0.36
+$0.00(+0.00%)
Market Cap$142504592
P/E Ratio
52W High$0.3602
52W Low$0.3353

AnGes, Inc. (AMGXF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · AMGXF · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.87B$0.64B$0.15B$0.07B$0.06B
Cost of Revenue$0.55B$0.40B$0.13B$2.99B$0.06B
Gross Profit$0.32B$0.25B$0.02B($2.92B)$0.01B
Gross Margin %(computed)36.65%38.48%12.71%11.58%
Operating Expenses
R&D Expenses$3.56B$3.78B$6.17B$10.99B$10.78B
G&A Expenses$0.00B$5.57B$5.81B$5.29B$4.86B
Total Operating Expenses$5.47B$9.36B$11.99B$13.40B$15.64B
Operating Income($5.15B)($9.11B)($11.97B)($16.32B)($15.63B)
Operating Margin %(computed)-588.64%
Interest Income$0.01B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.06B$0.01B$0.00B$0.00B
Income Before Tax($5.24B)($27.64B)($7.47B)($14.72B)($13.74B)
Income Tax Expense($0.11B)$0.49B($0.03B)($0.00B)($0.06B)
Net Income($5.13B)($28.13B)($7.44B)($14.71B)($13.68B)
Net Margin %(computed)-586.11%
Per Share & EBITDA
EPS (Basic)$-14.45$-126.54$-39.29$-94.29$-92.86
Wtd Avg Shares0.35B0.22B0.19B0.16B0.15B
EBITDA($5.10B)($5.74B)($8.86B)($13.41B)($13.21B)
EBITDA Margin %(computed)-582.48%-891.46%

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · JPY · B

Explore more AnGes, Inc. data

About AnGes, Inc. (AMGXF) Income Statement

AnGes, Inc. (AMGXF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AMGXF reported revenue of $0.87B, gross profit of $0.32B (gross margin 36.65%), and net income of ($5.13B) — a net profit margin of -586.11%.

Frequently asked questions

AMGXF · 4 questions

AnGes, Inc. (AMGXF) reported revenue of $0.87B for 2025, up 35.9% year-over-year.

AMGXF revenueAMGXF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08